Skip to main content

Find Clinical Trials

Home
Conditions
Healthy

Clinical trial condition

Healthy

Explore clinical trials studying Healthy. Study availability and eligibility vary by location and protocol.

9,864 public trials 452 recruiting studies

Refine in advanced search Browse all conditions

Healthy trial results

Completed

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

NCT01328184

Conditions: Healthy
Locations: 1245.41.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers

NCT01242176

Conditions: Healthy
Locations: 1245.51.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

Relative Bioavailability of Single Dose Empagliflozin (BI 10773) When Co-administered With Multiple Doses of 600 mg Gemfibrozil Compared to Single Dose Treatment With Empagliflozin (BI 10773) When Given Alone in Healthy Volunteers

NCT01301742

Conditions: Healthy
Locations: 1245.58.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

NCT01153997

Conditions: Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass, Healthy
Locations: Fukuoka, Japan

View Trial Details

Completed

DDI Between BI Empagliflozin (10773) and Verapamil

NCT01276301

Conditions: Healthy
Locations: 1245.43.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

NCT02018536

Conditions: Healthy
Locations: Cypress, California, United States

View Trial Details

Completed

Drug Interaction Study of Digoxin and BI 10773

NCT01306175

Conditions: Healthy
Locations: 1245.40.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects

NCT02117830

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

NCT01111318

Conditions: Digestive System Diseases, Healthy, Hepatic Insufficiency, +1 more
Locations: 1245.13.40001 Boehringer Ingelheim Investigational Site Timișoara, Romania

View Trial Details

Completed

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

NCT01610310

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Research Site Saint Paul, Minnesota, United States

View Trial Details